Document is current
Any future updates will be listed below
-
Authors
Ørskov, Marie https://orcid.org/0000-0002-1433-5528
Vorum, Henrik
Larsen, Torben Bjerregaard
Lip, Gregory Y. H.
Bek, Toke
Skjøth, Flemming
-
Funding
Funding for this research was provided by:
Det Obelske Familiefond
- License Information
-
More Information
Article History
Received: 1 October 2021
Accepted: 11 February 2022
First Online: 19 March 2022
Declarations
:
: HV has served as an advisory board member for Bayer and Novartis. TBL has been an investigator for Janssen Scientific Affairs, LLC, Bayer AG, and Boehringer Ingelheim; and has received speaker honorarium from Bayer, Bristol-Myers Squibb, Pfizer, and Merck Sharp & Dome. GYHL has been consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are received personally. FLS has received consultancy fees from Bayer.
: This article does not contain any studies with human participants performed by any of the authors.
